The Effect of Differential Proximal Myotomy Length On Esophagogastric Junction Distensibility During Heller Myotomy and Poem
Ezra N Teitelbaum, MD, Nathaniel J Soper, MD, Lubomyr Boris, BS, Frederic Nicodeme, MD, Peter J Kahrilas, MD, John E Pandolfino, MD, Eric S Hungness, MD. Northwestern University Feinberg School of Medicine. INTRODUCTION: For laparoscopic Heller myotomy (LHM), it has been shown that a myotomy extending 3cm distal to the esophagogastric junction (EGJ) results in… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Predicting Operative Techniques and Outcomes in Laparoscopic Paraesophageal Hernia Repair (PEHR) by Computed Tomography (CT) Measurements
Samuel W Ross, MD, MPH, Blair A Wormer, MD, Bindhu Oommen, MD, MPH, Mimi Kim, MD, John D Watkins, Amanda L Walters, MS, Vedra A Augenstein, MD, Brant T Heniford, MD. Carolinas Medical Center, Dept. of Surgery, Division of Gastrointestinal and Minimally Invasive Surgery. INTRODUCTION: Large PEHR can be challenging to plan pre-operatively given the… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Increased Incidence of Diaphragmatic Herniation after Minimally Invasive Esophagectomy – initial experience in a UK Specialist Unit
David E Messenger, MD, FRCS, Simon M Higgs, MD, FRCS, David F Hewin, MD, FRCS, Vipond N Mark, MD, FRCS, Hugh Barr, MD, FRCS, Simon J Dwerryhouse, MD, FRCS, Martin S Wadley, MD, FRCS. Worcestershire Royal Hospital, Worcester and Gloucestershire Royal Hospital, Gloucester, UK. INTRODUCTION The uptake of minimally invasive esophagectomy (MIE) in the UK… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Reoperation Rates After Nissen Fundoplication: an Analysis of the California Outcomes Database (oshpd)
Cristina R Harnsberger, MD, Tianzan Zhou, BA, David C Chang, PhD, MPH, MBA, Ryan C Broderick, MD, Hans F Fuchs, MD, Garth R Jacobsen, MD, Santiago Horgan, MD, Bryan J Sandler, MD. University Of California, San Diego. INTRODUCTION – Current literature on redo antireflux surgery has limitations due to small sample size or single center… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
24-hour multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms
Michelle S Han, MD, Michal J Lada, MD, Dylan R Nieman, MD, PhD, Andreas Tschoner, MD, Christian G Peyre, MD, Carolyn E Jones, MD, Thomas J Watson, MD, Jeffrey H Peters, MD. University of Rochester, Department of Surgery. INTRODUCTION: The detection of gastroesophageal reflux (GER) via ambulatory pH testing is a key component of the… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
A comparative trial of LINX versus Lap Nissen: caveats for patient selection
Eric G Sheu, MD, DPhil, Peter Nau, MD, Barbara Nath, MD, Braden Kuo, MD, David W Rattner, MD. Massachusetts General Hospital. Background: The LINX procedure, magnetic sphincter augmentation (MSA), is a promising new therapy for the treatment of gastroesophageal reflux disease (GERD). While initial clinical trials have shown MSA to be safe and effective, MSA… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Long-term Follow up after Laparoscopic Anti-reflux Surgery in patients with Barrett’s Esophagus
Ellen H Morrow, MD, Daniel Bushyhead, BA, Eelco Wassenaar, MD, Marcelo Hinojosa, MD, Maximiliano Loviscek, MD, Carlos Pellegrini, MD, Brant Oelschlager, MD. University of Washington. Introduction Barrett’s esophagus (BE) is caused by chronic gastro-esophageal reflux disease (GERD). It is hypothesized that laparoscopic anti-reflux surgery (LARS) may change the natural course of BE. The purpose… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Long Term Outcomes of Radiologic Recurrence After Paraesophageal Hernia Repair with Mesh
Rachel A Jones, MD, Anton Simorov, MD, Carl J Tadaki, MD, Dmitry Oleynikov, MD. University of Nebraska Medical Center, Department of General Surgery. Introduction: Paraesophageal hernia repair has historically had a high radiologic recurrence rate in the literature, even with the use of biologic mesh as a prosthetic buttress to reinforce the primary crural repair.… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Truncal Vagotomy Without Drainage: Are There Long Term Concerns?
Matt B Martin, MD. Central Carolina Surgery, PA, Cone Health, Greensboro, NC. Introduction: Panelists at SAGES 2012 implied that inadvertent vagotomy was the cause of the bloating, diarrhea, and delayed gastric emptying that is often seen after complex foregut reconstructions that require extensive esophageal dissection. Is it correct to ascribe these symptoms to vagotomy and… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Assessment and Reduction of Diaphragmatic Tension During Hiatal Hernia Repair
Brian E Louie, MD, Daniel Davila Bradley, MD, Peter Baik, MD, Alexander S Farivar, MD, Ralph W Aye, MD. Swedish Cancer Institute and Medical Center. Background: During hiatal hernia repair both axial tension along the esophagus and radial tension on the diaphragmatic hiatus need to be reduced in order to effect a successful repair and… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Laparoscopic Gastrectomy Versus Open Gastrectomy for Gastric Cancer in Patients with Body Mass Index of 30 kg/m2 or more.
Do Joong Park, MD, PhD, Sang-Yong Son, MD, Chang Min Lee, MD, Do-Hyun Jung, MD, Sang-Hoon Ahn, MD, Hyung-Ho Kim, MD, PhD. Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. Background: High body mass index (BMI) and high visceral fat area (VFA) are known to be a preoperative risk factor for laparoscopic gastrectomy… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Surgical Outcomes After Insertion of Gastric Neurostimulator for Refractory Gastroparesis-a Single Institution’s Experience
Ihab Saab, MD, Kellie McFarlin, MD. Henry Ford Hospital. INTRODUCTION: Gastric electric stimulation (GES) has been approved by the FDA under a humanitarian device exemption for treatment of patients with refractory symptoms of diabetic gastroparesis (DG) or idiopathic gastroparesis (IG). Our goal is to evaluate the effect of GES on body mass index (BMI) and… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
20-years Later: Laparoscopic Fundoplication Durability
Benjamin J Robinson, Christy M Dunst, MD, Kevin M Reavis, MD, Ahmed Sharata, MD, Lee L Swanstrom, MD. Gastrointestinal and Minimally Invasive Surgery Division, The Oregon Clinic. Introduction: The objective of this study is to present long-term 20-year outcomes after laparoscopic fundoplication. In the early 1990’s, this advanced surgery for gastrointestinal reflux disease (GERD) started… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Treatment of foregut fistulas with biologic fistula plugs
Rhys Filgate, Dr, Alan Thomas, Mr, Mohammed Ballal, Assoc, Professor. School of Surgery, University of Western Australia. Introduction Enteric fistulas are a recognized complication of various diseases and surgical interventions. 15-25% are spontaneous and are most commonly associated with Chron’s disease, malignancy and infection. The remaining 75-85% are iatrogenic and arise most frequently as a… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut
Laparoscopic Revision Anti-Reflux Surgery for Prior Failed Transoral Incisionless Fundoplication is Safe – Technical Details.
Reginald Bell, MD, Kate Bell, NP, Carrie Morrison, PA, Ashwin A Kurian, MD. SurgOne Foregut Institute. Background: Transoral Incisionless Fundoplication (TIF) treats gastro-esophageal reflux disease (GERD) by creating full-thickness esophagogastric plications using transmural fasteners. Laparoscopic revision anti-reflux surgery for failed TIF has been reported, albeit with increased perforation risk secondary dissecting the transmural fasteners. We… Continue Reading
- Type:
- Podium Presentations
- Topic:
- Foregut